New weight loss drug to be sold on Trump's pharmaceutical cost comparison platform - CBS News

New weight loss drug to be sold on Trump's pharmaceutical cost comparison platform  CBS NewsFDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions  Eli LillyThe FDA approves a new obesity pill, giving patients another option  NPRA new weight-loss pill is here — and could rival Wegovy and Zepbound. Here's how it compares.  Business InsiderWall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead  Reuters